| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $47.8M | — | +16.5% |
| Cost of Revenue | $25.9M | — | +15.6% |
| Gross Profit | $21.9M | — | +17.6% |
| R&D Expense | $3.9M | — | -0.7% |
| SG&A Expense | $27.6M | — | +14.2% |
| Operating Income | -$9.6M | — | -1.4% |
| Pre-tax Income | -$9.3M | — | -6.0% |
| Income Tax | $108K | — | -53.8% |
| Net Income | -$10.5M | — | +12.0% |
| EPS (Basic) | -$0.25 | — | +10.7% |
| EPS (Diluted) | -$0.25 | — | +10.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $272.9M | +8.9% | +655.9% |
| Short-term Investments | $130.7M | -18.7% | -37.1% |
| Accounts Receivable | $39.0M | +16.9% | +37.5% |
| Inventory | $21.8M | -6.2% | -6.8% |
| Current Assets | $470.5M | -1.2% | +14.4% |
| Total Assets | $763.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $3.7M | — | +186.0% |
| Capital Expenditures | $10.0M | — | +215.1% |
| Investing Cash Flow | $18.7M | — | +216.1% |
| Financing Cash Flow | $85K | — | +145.0% |
| Free Cash Flow | -$6.2M | — | +16.8% |
| +9.1% |
| Current Liabilities | $224.9M | +2.7% | +203.8% |
| Total Liabilities | $268.6M | +2.4% | -10.8% |
| Stockholders' Equity | $495.0M | -1.5% | +24.1% |